Virus Diseases  >>  Mifeprex (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
NCT00352911: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Completed
2
19
US
VGX-410 (Mifepristone), Mifeprex, Placebo for VGX-410 (Mifepristone)
VGX Pharmaceuticals, LLC
HIV Infections
06/07
11/07
NCT00255177: Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Completed
2
44
US
VGX-410 (Mifepristone), Mifepristone, Placebo
VGX Pharmaceuticals, LLC
Hepatitis C Virus Infection
09/07
01/08

Download Options